Together We Can End HIV. Join a Paid Study.

New York City NY

Description

Columbia Research Unit and Project Achieve are conducting a phase 3 HIV vaccine efficacy study called the Mosaico study. The Mosaico study aims to enroll 3,800 people in the United States, South America, and Europe. The Mosaico study will include people who are • HIV-negative • who are NOT on PrEP, and • who are from 18-60 years old. • You can't get HIV from the test vaccines and antibodies. Participants will be compensated up to $900 if all study visits are completed. Click on to find out if you meet basic criteria.